GlassScriptPhysician profile
Jeffrey M Albert
NPI 1003166109
$982.80
in general payments reported to CMS, 2019-2025
15 companies · $61.76 in 2025
The $61.76 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $366 · 2022: $265 · 2023: $103 · 2024: $188 · 2025: $61.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $352.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $352.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Elekta, INC. | $204.53 | 2019 | |
| Sumitomo Pharma America, INC. | $178.39 | 2023-2025 | Orgovyx |
| Varian Medical Systems, INC. | $129.30 | 2019 | |
| Zap Surgical Systems, INC. | $120.87 | 2022 | |
| Viewray Technologies INC | $85.57 | 2022 | |
| Myovant Sciences INC. | $58.54 | 2022 | |
| Intra-Sana Laboratories | $50.00 | 2024 | Reltone 200 Mg, Reltone 400 Mg |
| Teleflex LLC | $25.89 | 2024 | |
| Hyperfine Operations, INC. | $24.88 | 2023 | Swoop |
| Boston Scientific Corporation | $23.52 | 2023 | |
| Novocure INC. | $18.83 | 2024 | Optune |
| Taiho Oncology, INC. | $16.55 | 2019 | |
| Siemens Medical Solutions USA, INC. | $15.59 | 2025 | Edge |
| E.R. Squibb & Sons, L.L.C. | $15.38 | 2019 | |
| Tactile Systems Technology INC | $14.96 | 2023 | Flexitouch Plus, Entre Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Albert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.